Contact Us
ENGLISH
Hefei KS-V Peptide Biological Technology Co., Ltd. Hefei KS-V Peptide Biological Technology Co., Ltd.
Hefei KS-V Peptide Biological Technology Co., Ltd.
Membrane Protein
  • membrane protein of ksv
  • membrane protein of ksv

Membrane Protein

Category: Protein -

The KS-V Peptide team has more than 20 years of high-expression vector design, expression condition screening, membrane protein purification and rapid detection platforms for membrane protein targets based on eukaryotic expression systems.


Detailed Introduction of Membrane Protein



GPCR proteins

G protein-coupled receptors (GPCRs) are membrane proteins that regulate various cellular responses to external stimuli. It is involved in a variety of diseases and is an important drug target; more than 50% of modern protein drugs are related to GPCRs. As membrane proteins, GPCRs are very large, structurally flexible, and difficult to crystallize.


G protein-coupled receptors are one of the largest members of the receptor protein family. They play important biological functions in the process of cell signal transduction and are important drug targets. Extracellular drugs or ligands bind to different types of receptors, the receptors are activated, and the signals are transmitted to downstream effectors by activating G protein heterotrimers, through second messengers (cAMP or IP-one, etc.) Regulates the activity of membrane ion channels and nuclear transcription.


GPCR target - completed target




GPCR Cell Line Construction Services


● Cell line validation

1. mRNA integration

2. Cell membrane surface expression (specific tags)

3. Has functional activity

● Method development

1. Liposome cis-transfer

2. Lentiviral Infection-Stable Transfection

● Monoclonal cell screening

3 functional cell lines

Validation of 2 blank cell lines

● GPCR cell bank

Further validation using molecular pharmacology and other methods


Fully autonomously constructed GPCR stably transfected cell line


Glucagon receptor family stable cell lines (GLP1R, GIPR, GCGR) have been established, and more GPCR target cell banks are being constructed in batches.

Advantages: The cell line construction cycle is 6-8 weeks, and the functional verification is two weeks.

Fully_autonomously_constructed_GPCR_stably_transfected_cell_line.jpeg


GPCR functional detection case 1 (GPCR coupled with Gαs)


Technology Platform: FlexStation 3, BMG LABTECH CLARIOstar, FLPR

GPCR: β2-adrenergic receptor (β2-adrenergic receptor, β2AR)

Observation indicators: dose-response curve, EC50 of drug

Experiment report: standard report, in line with GLP specification


β2-adrenergic receptor:



GPCR_functional_detection_case_1_(GPCR_coupled_with_Gαs).jpg


Ion channel

As an important target, ion channel is the second largest drug target after GPCR. It occupies an important position in the research and development of new drugs for the central nervous system and cardiovascular system, and is a rapidly growing hot spot in drug research and development. More than 400 genes are known to encode ion channels, and 300 ion channels have been identified. Among them, there are more than 100 druggable targets with known functions, many of which are proven therapeutic targets.

Among them, ligand-gated and voltage-gated ion channels are ranked third and fourth respectively among the top five gene targets of existing drugs. After G protein-coupled receptors (GPCRs) and the nuclear receptor family. At present, the hot areas of ion channel targets include pain (Nav1.7, ASIC, etc.), epilepsy (potassium channel) and cardiac safety evaluation (hERG), etc.


Ion Channel Targets - Targets Completed


Ion_Channel_Targets_-_Targets_Completed.jpg



Ion Channel Drug Efficacy Testing Case 1


Technology Platform: Manual Patch Clamp

Ion channels: Kv1.1, Kv1.2, Kv1.3, hERG, IK, SK3 channels

Observation indicators: dose-response curve, IC50 of the drug

Experiment report: standard report, in line with GLP specification

● Inhibitory effect of BmKDfsin3 on potassium channels

case_ofIon_Channel_Drug_Efficacy_Testing_Case_1.jpg



● Kv1.3 channel


Kv1.3_channel.jpg


Ion Channel Drug Efficacy Testing Case 2


Technology Platform: Calcium Flow Detection-FLIPRTM

Ion channel: nicotinic acetylcholine receptor (nAChR)

Observation indicators: dose-response curve, EC50 of drug

Experiment report: standard report, in line with GLP specification

● nicotinic acetylcholine receptor

Cases_of_Ion_Channel_Drug_Efficacy_Testing.jpg


KS-V PEPTIDE — PROVIDES THE BEST PEPTIDE SOLUTION.